Current trends in treatment of uterine fibroids. A Perspective Review of Recent Literature
DOI:
https://doi.org/10.12775/QS.2026.57.72546Keywords
uterine fibroids, myomectomy, hysterectomy, uterine artery embolizationAbstract
Uterine fibroids, or leiomyomas, are the most prevalent benign tumors in the female reproductive tract, affecting up to 70–80% of women by age 50. These tumors, which are composed of smooth muscle and connective tissue, often arise during the reproductive years and are influenced by a combination of genetic and hormonal factors. While many fibroids are asymptomatic, a significant number of women experience debilitating symptoms such as heavy menstrual bleeding, pelvic pressure, pain, and infertility, necessitating the need for effective treatment options. Historically, hysterectomy was the primary treatment; however, the desire for fertility preservation and advancements in medical technology have led to the emergence of minimally invasive and non-surgical treatment alternatives, including myomectomy, uterine artery embolization (UAE), and pharmacological therapies. Each treatment modality presents unique benefits and risks and should be tailored to individual patient factors, such as fibroid characteristics and reproductive goals. Despite the evolution of treatment options, awareness remains limited among patients, underscoring the need for enhanced patient education and shared decision-making in fibroid management. This review synthesizes current literature on the efficacy of various treatment strategies for uterine fibroids, highlighting the importance of personalized, evidence-based approaches to improve clinical outcomes and quality of life for women affected by this condition. This perspective review summarizes recent literature on current treatment options and trends, focusing on myomectomy, hysterectomy, embolization, and non-invasive techniques of uterine fibroids.
References
Micić, D. et al. (2024). Current challenges and modern approaches in uterine fibroid management. Biomedicines, 12(2), 266. ttps://doi.org/10.3390/biomedicines12020266
Xiromeritis, K. et al. (2011). UAE as treatment for fibroids. The Internet Journal of Gynecology and Obstetrics, 15(2).
Chen, R. & You, J. (2022). Comparison of hysterectomy and UAE. Medicine, 101(52), e32440. https://doi.org/10.1097/md.0000000000032440
Shrivastava, R. et al. (2023). Current management of uterine fibroids. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 12(7), 2063–2070. https://doi.org/10.18203/2320-1770.ijrcog20232092
Dou, L. & Zhang, Y. (2022). Robotic myomectomy: single-center experience. Journal of Clinical Medicine, 11(11), 3221. https://doi.org/10.3390/jcm11113221
Alexander, K., C, S., & Tanos, V. (2023). Minimally invasive techniques in myomectomy and fertility outcomes: a narrative review. https://doi.org/10.22541/au.169461382.27823786/v1
Tahapary, R. et al. (2023). Minimally invasive gynecologic surgery in Indonesia. Obstetrics and Gynecology International, 2023, 1555246. https://doi.org/10.1155/2023/1555246
Clark, T. et al. (2024). ESGE good practice recommendations on hysteroscopic myomectomy. Facts Views Vis Obgyn, 16(4), 383–397. https://doi.org/10.52054/fvvo.16.4.054
Lewis, E. & Gargiulo, A. (2016). Role of hysteroscopic and robot-assisted myomectomy. Clinical Obstetrics & Gynecology, 59(1), 53–65. https://doi.org/10.1097/grf.0000000000000161
Ivanova, Y. et al. (2022). Use of HIFU in uterine fibroids. J Biomed Clin Res, 15(2), 178–181. https://doi.org/10.2478/jbcr-2022-0025
Bălulescu, L. et al. (2023). Uterine isthmus tourniquet in myomectomy. Medicina, 59(11), 1979. https://doi.org/10.3390/medicina59111979
Wang, X. et al. (2020). Comparison of laparoscopic vs abdominal myomectomy. Medicine, 99(41), e22547. https://doi.org/10.1097/md.0000000000022547
Siedhoff, M. & Kim, K. (2015). Complications of myomectomy. Clinical Obstetrics & Gynecology, 58(1), 168–180. https://doi.org/10.1097/grf.0000000000000094
Barron, K. et al. (2015). Association of FDA morcellation warning with rates of minimally invasive hysterectomy. Obstetrics and Gynecology, 126(6), 1174–1180. https://doi.org/10.1097/aog.0000000000001111
Yang, F. et al. (2022). Comparison of surgical routes for hysterectomy. BioMed Research International, 2022, 7554286. https://doi.org/10.1155/2022/7554286
Williams, A. et al. (2022). UAE for fibroids review. Cureus, 14(12), e32661. https://doi.org/10.7759/cureus.32661
Mohan, P. et al. (2022). UAE for symptomatic fibroids. Cureus, 14(1), e21113. https://doi.org/10.7759/cureus.21113
Stępniak, A. (2018). Uterine artery embolization for fibroids. Polish Journal of Radiology, 83, e253–e259. https://doi.org/10.5114/pjr.2018.76827
Hesley, G. et al. (2012). MR-guided focused ultrasound for fibroids. Cardiovasc Intervent Radiol, 36(1), 5–13. https://doi.org/10.1007/s00270-012-0367-3
Zaher, S. et al. (2010). HIFU treatment for uterine fibroids. International Journal of Hyperthermia, 26(3), 244–255. https://doi.org/10.3109/02656730903580142
Kim, Y. (2017). High-intensity focused ultrasound for fibroids. Biomedical Engineering Letters, 7(2), 99–105. https://doi.org/10.1007/s13534-017-0012-9
Donnez, J. et al. (2015). Repeated use of ulipristal acetate in uterine fibroids. Fertility and Sterility, 103(2), 519–527.e3. https://doi.org/10.1016/j.fertnstert.2014.10.038
Garnock-Jones, K. & Duggan, S. (2017). Ulipristal acetate review in symptomatic fibroids. Drugs, 77(15), 1665–1675. https://doi.org/10.1007/s40265-017-0812-3
Baggio, S. et al. (2018). Influence of ulipristal acetate therapy on uterine fibroid‐related symptoms. Journal of Ultrasound in Medicine, 37(9), 2215–2223. https://doi.org/10.1002/jum.14573
Pohl, O. et al. (2015). The pharmacokinetics of ulipristal acetate. Drug Metabolism and Disposition, 43(5), 776–783. https://doi.org/10.1124/dmd.114.060954
Deshpande, P. & Deshpande, S. (2019). Effect of ulipristal acetate for uterine fibroids. J Evol Med Dent Sci, 8(49), 3675–3678. https://doi.org/10.14260/jemds/2019/795
Wdowiak, A. (2013). The role of ulipristal acetate. Przegląd Menopauzalny, 17(4), 296–299. https://doi.org/10.5114/pm.2013.39194
Alreshidi, M., Alshubrmi, D., Alrashidi, I., & Arabi, M. (2020). Awareness of uterine artery embolization as a treatment for fibroids among Saudi women. Arab Journal of Interventional Radiology, 4(02), 79–82. https://doi.org/10.4103/ajir.ajir_21_20
Clark, T., Antoun, L., Sardo, A., Tanos, V., Huirne, J., Bousma, E., … & Saridogan, E. (2024). European society for gynaecological endoscopy (esge) good practice recommendations on surgical techniques for removal of fibroids: part 2 hysteroscopic myomectomy. Facts Views and Vision in Obgyn, 16(4), 383-397. https://doi.org/10.52054/fvvo.16.4.054
Kim, S. and Lee, K. (2023). Optimal energy use for robot-assisted laparoscopic myomectomy. Gynecologic Robotic Surgery, 4(2), 31-36. https://doi.org/10.36637/grs.2023.00185
Hertling, S., Schleußner, E., & Graul, l. (2023). Validation of uterine artery embolization before surgical laparoscopic myomenucleation compared to single surgical laparoscopic myomenucleation for the treatment of large fibroids and uterus myomatosus. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1145952
Zhang, D., Huang, Y., Peng, C., & Zhou, Y. (2024). Effect of dienogest treatment on uterine fibroid volume in patients with endometriosis or adenomyosis complicated by uterine fibroids. World Journal of Clinical Cases, 12(21), 4601-4608. https://doi.org/10.12998/wjcc.v12.i21.4601
Acchiardo, J., Maita, E., & Jobanputra, K. (2023). Ultrasound-guided diagnosis of multiple uterine fibroids in a patient with polycystic ovaries and treatment with relugolix, estradiol, and norethisterone acetate. Cureus. https://doi.org/10.7759/cureus.39055
Afaq, M. (2025). Uterine fibroids and their association with acute and chronic venous thromboembolic disease—an expert review of the literature. Journal of Clinical Medicine, 14(12), 4065. https://doi.org/10.3390/jcm14124065
El-Sharkawy, A., Elsaeed, H., Kamel, A., Morgan, R., & Elshafey, M. (2020). Comparison between the outcome of single versus multiple uterine fibroids after uterine artery embolization. Egyptian Journal of Radiology and Nuclear Medicine, 51(1). https://doi.org/10.1186/s43055-020-00192-4
Jha, S., Inamdar, S., & Dhobale, A. (2024). Case report: uterine artery embolization after dysfunctional uterine bleeding due to incomplete abortion in female. F1000research, 13, 473. https://doi.org/10.12688/f1000research.142066.1
Bonafede, M., Pohlman, S., Miller, J., Thiel, E., Troeger, K., & Miller, C. (2018). Women with newly diagnosed uterine fibroids: treatment patterns and cost comparison for select treatment options. Population Health Management, 21(S1), S-13-S-20. https://doi.org/10.1089/pop.2017.0151
Evans, J. and Jones, K. (2024). The role of socioeconomic status in uterine fibroid awareness and treatment: a narrative review. Therapeutic Advances in Reproductive Health, 18. https://doi.org/10.1177/26334941241297634
Aghogho, E., Iru, N., Simeon, A., Mike, E., & Tudjegbe, O. (2024). Knowledge and perception towards uterine fibroids among ante-natal clinic attendees in two sub-urban communities in delta state, nigeria. Dutse Journal of Pure and Applied Sciences, 9(4a), 290-301. https://doi.org/10.4314/dujopas.v9i4a.27
Catanese, A., et al. (2022). Factors influencing surgical outcomes of laparoscopic myomectomy. Menopausal Review, 21(3), 149–156. https://doi.org/10.5114/pm.2022.118970
Shen, F., et al. (2015). Laparoscopic vs. abdominal myomectomy: A meta-analysis. Eur J Obstet Gynecol Reprod Biol, 195, 52–60.
Wang, T., et al. (2020). Clinical comparison of RAM and LM. Minim Invasive Ther Allied Technol, 29(1), 38–43.
Flyckt, R., et al. (2016). Robotic myomectomy and reproductive outcomes: A review. Obstet Gynecol Int. https://doi.org/10.1155/2016/2789201
Williamson, K., & Song, H. K. (2022). Robotic fibroid surgery: Cost-effectiveness and adoption trends. Surg Technol Int, 41, 113–119.
Aktürk, E., et al. (2023). Comparative outcomes in uterine-sparing procedures for fibroids
Rodriguez-Triana, O., et al. (2021). Myomectomy outcomes in fertility preservation. J Gynecol Obstet Hum Reprod, 50(10), 102110.
Khaw, K., et al. (2020). Fertility outcomes post-myomectomy. Human Fertility, 23(4), 276–282.
Malzoni, M., et al. (2010). Robotic-assisted laparoscopic myomectomy and reproductive outcomes. Fertil Steril, 94(6), 2474–2478.
Jindal, S., et al. (2023). Surgical complications in fibroid management. Gynecologic Surgery Reports, 10(2), 45–51.
Lyon, D. S., et al. (2019). Impact of hysterectomy on quality of life and hormones. Menopause, 26(1), 45–50.
Jiang, H., et al. (2021). Hysterectomy and hormonal implications. Gynecol Endocrinol, 37(12), 1076–1082.
Bian, Y., & Gu, S. (2024). Modern fibroid management: Surgical and non-surgical perspectives.
Kroencke, T. J., et al. (2010). Uterine artery embolization in fibroids: Outcomes after 6 months. Radiology, 257(2), 647–657.
Erciyestepe, A., et al. (2023). Quality of life outcomes post-UAE. Interventional Radiology Journal.
Bonduki, C., et al. (2011). Pregnancy after uterine arterial embolization. Clinics, 66(5), 807–810. https://doi.org/10.1590/s1807-59322011000500016
Himiniuc, A., et al. (2021). Pregnancy outcomes after uterine artery embolization. Journal of Clinical Medicine, 10(5), 1082.
Mutiso, S. K., et al. (2018). Reproductive outcomes post-UAE: A comparative study. BMC Women's Health, 18, 123.
Đức, N., & Keserci, B. (2018). Clinical factors in MRI-guided HIFU outcomes. Diagn Interv Radiol, 24(5), 283–291. https://doi.org/10.5152/dir.2018.18111
Chen, J., et al. (2016). Volumetric MR-guided HIFU: Early experience in China. J Ther Ultrasound, 4(1). https://doi.org/10.1186/s40349-016-0072-9
Patel, R., et al. (2023). Safety and efficacy of HIFU: Current perspective. Ultrasound Med Biol, 49(1), 103–112.
Krzyżanowski, T., et al. (2024). Oral therapies for uterine fibroids: A review. Int J Gynecol Pharmacol, 10(1), 5–12.
Kalampokas, T., et al. (2015). Ulipristal acetate in uterine fibroids: A systematic review. Eur J Obstet Gynecol Reprod Biol, 191, 45–51.
Donnez, J., et al. (2015). Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril, 103(2), 519–527.e3. https://doi.org/10.1016/j.fertnstert.2014.10.038
Donnez, J., & Dolmans, M.-M. (2016). Uterine fibroid management: Ulipristal acetate and surgical options. Fertil Steril, 106(6), 1339–1353.
Bao, X., et al. (2024). Fertility outcomes after fibroid treatments. Journal of Reproductive Medicine.
Fatima, I., & Amir, S. (2021). Fibroid recurrence after uterine-sparing procedures: A review. Obstetrics and Gynecology International.
Kotani, Y., et al. (2024). Long-term outcomes and recurrence after fibroid surgery. J Obstet Gynaecol Res.
Alexander, K., C., S., & Tanos, V. (2023). Minimally invasive techniques in myomectomy and fertility outcomes: A narrative review. https://doi.org/10.22541/au.169461382.27823786/v1
Kaneda, H., et al. (2017). Robotic surgery ergonomics and patient satisfaction. Surgical Endoscopy, 31(3), 1307–1314.
Li, S. (2023). Curative effect and complication rate of abdominal myomectomy and laparoscopic myomectomy in the treatment of uterine fibroids. Advances in Obstetrics and Gynecology Research, 1(1), 43-48. https://doi.org/10.26689/aogr.v1i1.5062
Shi, X., Wu, H., Liu, J., Zhu, J., & Zhang, L. (2024). Laparoscopic continuous seromuscular circumsuture for myomectomy: a real-world, retrospective, east-asian cohort study. BMJ Open, 14(3), e081550. https://doi.org/10.1136/bmjopen-2023-081550
X, L., Tang, J., Luo, Y., Wang, Y., Song, L., & Wang, W. (2020). Comparison of high‐intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. Bjog an International Journal of Obstetrics & Gynaecology, 127(11), 1422-1428. https://doi.org/10.1111/1471-0528.16262
Bahall, V., Barry, L., & Singh, K. (2023). The hangman’s tourniquet: a safe and practical approach for reducing blood loss during uterine myomectomy. Cureus. https://doi.org/10.7759/cureus.50662
McDougall, A., Rouabhi, S., Magama, Z., & Odejinmi, F. (2022). Laparoscopic myomectomy to facilitate laparoscopic resection of a bleeding interstitial ectopic pregnancy. BMJ Case Reports, 15(9), e250584. https://doi.org/10.1136/bcr-2022-250584
Asati, P., Asati, S., Sinha, V., Dixit, H., Mahajan, A., Alraddadi, Y. & Syed, A. (2024). Evaluation of the efficacy and complications of different hysterectomy techniques in the management of uterine fibroids. Journal of Pharmacy and Bioallied Sciences, 16(Suppl 3), S2428-S2430. https://doi.org/10.4103/jpbs.jpbs_236_24
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Kinga Bylica, Łukasz Dylewicz, Joanna Brzoza , Jakub Rudzki, Wojciech Warmuz, Ewa Wystalska, Kacper Solarz, Natalia Czołpińska, Zuzanna Kata, Jakub Andrzejewicz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 5
Number of citations: 0
